Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
ID: 357375Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357375

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-158.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (FASD)" under the R61/R33 exploratory/developmental phased award mechanism. This initiative aims to support research focused on developing and evaluating prevention strategies to reduce prenatal alcohol exposure and interventions to mitigate the effects of FASD throughout the lifespan. The funding is critical for addressing the public health issue of prenatal alcohol exposure, with a funding cap of $350,000 for the R61 phase (two years) and $500,000 annually for the R33 phase (three years). Interested applicants, including various educational institutions and organizations, must submit their applications by November 17, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-158-Full-Announcement.html
    PAR-25-158.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announces a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (FASD)" under the R61/R33 exploratory/developmental phased award mechanism. The initiative seeks to advance research on strategies for preventing prenatal alcohol exposure and mitigating effects of FASD across the lifespan. Specifically, the funding aims to support projects that develop and evaluate clinical trials or interventions aimed at reducing the incidence of FASD and improving outcomes for affected individuals. Key details include a funding cap of $350,000 for the R61 phase (two years) and $500,000 annually for the R33 phase (three years), with application due dates between January 2025 and October 2026. Eligible applicants include various educational institutions and organizations, both domestic and foreign, and applications must align with scientific and technical merit criteria focused on significance, innovation, rigor, and feasibility. The initiative highlights the critical need for evidence-based interventions to tackle the prevalent issue of prenatal alcohol exposure, promoting further research in this vital public health area.
    Similar Opportunities
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)" aimed at supporting research on strategies to prevent and intervene in fetal alcohol spectrum disorders (FASD). The initiative seeks proposals that focus on reducing prenatal alcohol exposure and improving interventions for individuals affected by FASD, utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, which allows for pilot studies in the initial phase and potential expansion in the subsequent phase based on milestone achievements. This funding is crucial for addressing significant public health challenges related to prenatal alcohol exposure, with a total award ceiling of $350,000 and no cost-sharing requirements. Interested applicants must submit their proposals by January 16, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for R34 planning grants aimed at supporting research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD). This initiative seeks applications that will contribute to evidence-based strategies to reduce prenatal alcohol exposure and improve outcomes for individuals affected by FASD, with a focus on innovative studies that can provide pilot or feasibility data for larger-scale research. The maximum budget for the three-year project period is set at $450,000, and eligible applicants include various higher education institutions, nonprofits, and state and local governments. Interested parties should note that the earliest submission date is January 16, 2025, with the application deadline extending to January 7, 2027; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R34 Clinical Trial Optional grant program to support research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD). The primary objective of this grant is to develop evidence-based strategies aimed at reducing prenatal alcohol exposure and the incidence of FASD, while also conducting preliminary studies necessary for larger-scale projects. This initiative is crucial for advancing public health, particularly in the field of maternal and child health, by addressing the challenges associated with prenatal alcohol exposure. Eligible applicants can receive up to $450,000 over three years, with applications accepted until January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-067.html.
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a Notice of Funding Opportunity (NOFO) titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)." This initiative aims to enhance the HIV prevention toolkit for populations affected by alcohol consumption, focusing on the integration of effective prevention and treatment interventions to reduce the incidence of new HIV infections. The program is particularly relevant for high-risk groups, including men who have sex with men, transgender individuals, and others impacted by alcohol-related HIV transmission, emphasizing the need for innovative strategies to address health disparities. The funding opportunity offers a total estimated program funding of $1.5 million for 2-4 awards, with individual project budgets capped at $450,000, and applications are due by May 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and should refer to the full announcement for detailed application guidelines.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)," aimed at advancing translational research in the field of substance use. This initiative encourages researchers to engage in a two-phase research process, starting with an R61 planning phase lasting up to two years, followed by an R33 phase for larger studies that may extend up to four years, contingent upon meeting specific milestones. The program emphasizes the importance of community stakeholder engagement and mandates a Plan for Enhancing Diverse Perspectives (PEDP) in all proposals to ensure inclusivity in research development. Interested applicants can find more information and submit their proposals by December 14, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), is offering a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)." This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing treatment appeal, analyzing cost structures, promoting the dissemination of evidence-based approaches, and reducing health disparities among underserved populations. The program invites applications for R34 Planning Grants with a budget limit of $450,000 over a three-year period, encouraging innovative research designs and strategies to improve alcohol health services. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for September 7, 2026.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R01 Clinical Trial Optional)" aimed at addressing the treatment gap for individuals with Alcohol Use Disorder (AUD). This initiative focuses on five key areas: increasing access to treatment, enhancing the appeal of treatment options, analyzing cost structures and insurance systems, studying the dissemination of evidence-based practices, and reducing health disparities among affected populations. The program encourages innovative research designs and participation from diverse organizations, with a maximum budget of $500,000 available for direct costs over a five-year project period. Interested applicants can submit proposals starting January 5, 2025, and should direct inquiries to grantsinfo@nih.gov for further information.